Automated Drug Coding Using Artificial Intelligence: An Evaluation of WHODrug Koda on Adverse Event Reports.

Eva-Lisa Meldau Shachi BistaEmma RoforsLucie M Gattepaille

Published in: Drug safety (2022)

Even though Koda was designed for use in clinical trials, Koda achieves automation level and coding quality for drug coding of AE reports comparable with the performance observed in a previous evaluation of Koda on clinical trial data. Koda can thus help organisations to automate their drug coding of AE reports to a large degree.

Keyphrases

adverse drug
clinical trial
artificial intelligence
machine learning
big data
deep learning
electronic health record
phase ii
emergency department
open label
drug induced
randomized controlled trial
study protocol
high throughput
quality improvement
single cell
data analysis